GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $24,452,000 | -6.1% | 561,708 | -6.1% | 0.02% | +4.3% |
| Q1 2022 | $26,049,000 | -6.8% | 598,024 | -5.6% | 0.02% | 0.0% |
| Q4 2021 | $27,935,000 | +8.1% | 633,478 | -6.3% | 0.02% | -4.2% |
| Q3 2021 | $25,834,000 | -6.5% | 676,113 | -2.5% | 0.02% | -4.0% |
| Q2 2021 | $27,618,000 | +5.3% | 693,581 | -5.6% | 0.02% | 0.0% |
| Q1 2021 | $26,218,000 | +0.1% | 734,612 | +3.2% | 0.02% | -3.8% |
| Q4 2020 | $26,188,000 | -14.5% | 711,646 | -12.5% | 0.03% | -31.6% |
| Q3 2020 | $30,628,000 | -11.0% | 813,706 | -3.5% | 0.04% | -17.4% |
| Q2 2020 | $34,397,000 | +5.7% | 843,257 | -1.8% | 0.05% | +12.2% |
| Q1 2020 | $32,545,000 | -19.4% | 858,959 | -0.0% | 0.04% | +2.5% |
| Q4 2019 | $40,369,000 | +10.9% | 859,093 | +0.7% | 0.04% | +11.1% |
| Q3 2019 | $36,404,000 | +1.1% | 852,943 | -5.2% | 0.04% | +2.9% |
| Q2 2019 | $36,006,000 | -6.9% | 899,684 | -2.7% | 0.04% | -10.3% |
| Q1 2019 | $38,657,000 | +8.5% | 925,041 | -0.8% | 0.04% | -2.5% |
| Q4 2018 | $35,641,000 | -7.8% | 932,777 | -3.1% | 0.04% | +8.1% |
| Q3 2018 | $38,655,000 | -2.9% | 962,304 | -2.6% | 0.04% | -5.1% |
| Q2 2018 | $39,820,000 | +3.0% | 987,832 | -0.2% | 0.04% | +2.6% |
| Q1 2018 | $38,673,000 | +7.5% | 989,836 | -2.4% | 0.04% | +8.6% |
| Q4 2017 | $35,963,000 | -21.0% | 1,013,915 | -9.5% | 0.04% | -25.5% |
| Q3 2017 | $45,499,000 | -6.9% | 1,120,694 | -1.1% | 0.05% | -11.3% |
| Q2 2017 | $48,881,000 | +2.6% | 1,133,608 | +0.3% | 0.05% | 0.0% |
| Q1 2017 | $47,637,000 | +6.4% | 1,129,910 | -2.8% | 0.05% | +3.9% |
| Q4 2016 | $44,789,000 | -17.6% | 1,163,047 | -7.7% | 0.05% | -19.0% |
| Q3 2016 | $54,348,000 | -6.1% | 1,260,108 | -5.6% | 0.06% | -7.4% |
| Q2 2016 | $57,849,000 | +5.5% | 1,334,783 | -1.3% | 0.07% | +6.2% |
| Q1 2016 | $54,843,000 | +5.6% | 1,352,477 | +5.1% | 0.06% | +4.9% |
| Q4 2015 | $51,929,000 | -14.4% | 1,286,920 | -18.4% | 0.06% | -15.3% |
| Q3 2015 | $60,674,000 | -16.6% | 1,578,015 | -9.6% | 0.07% | -11.1% |
| Q2 2015 | $72,728,000 | -32.9% | 1,746,154 | -25.7% | 0.08% | -31.9% |
| Q1 2015 | $108,456,000 | +27.4% | 2,350,080 | +18.0% | 0.12% | +26.6% |
| Q4 2014 | $85,121,000 | -5.3% | 1,991,600 | +1.9% | 0.09% | -11.3% |
| Q3 2014 | $89,851,000 | +0.5% | 1,954,571 | +16.9% | 0.11% | -7.0% |
| Q2 2014 | $89,397,000 | +2.9% | 1,671,578 | +2.8% | 0.11% | 0.0% |
| Q1 2014 | $86,871,000 | +11.7% | 1,625,899 | +11.6% | 0.11% | +10.7% |
| Q4 2013 | $77,749,000 | +12.2% | 1,456,261 | +5.4% | 0.10% | +2.0% |
| Q3 2013 | $69,283,000 | +8.3% | 1,380,999 | +7.9% | 0.10% | +7.4% |
| Q2 2013 | $63,984,000 | – | 1,280,466 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |